[Preventive effect of liquemin depot in thromboembolism; experimental proof with myotoxin thrombokinase test].
D000925:Anticoagulants; D003435:Crotalid Venoms; D004809:Ephedrine / Q000627:therapeutic use*; D015951:Factor Xa; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D003435:Crotalid Venoms; C018932:myotoxin A; D006493:Heparin; D015951:Factor Xa; D004809:Ephedrine
EPHEDRINE/therapeutic use; HEPARIN/therapeutic use; THROMBOEMBOLISM/prevention and control
Uber die thromboembolieverhütende Wirkung des Liquemin Depot; tierexperimentelle Prüfung mit dem Myotoxin-Thrombokinase-Test.